Eldad Melamed
#112,981
Most Influential Person Now
Eldad Melamed's AcademicInfluence.com Rankings
Eldad Melamedphilosophy Degrees
Philosophy
#4799
World Rank
#7448
Historical Rank
Logic
#2184
World Rank
#3119
Historical Rank
Eldad Melamedbiology Degrees
Biology
#6363
World Rank
#9060
Historical Rank
Neuroscience
#771
World Rank
#803
Historical Rank
Download Badge
Philosophy Biology
Eldad Melamed's Degrees
- PhD Neuroscience University of California, San Francisco
- Doctorate Medicine University of California, San Francisco
Why Is Eldad Melamed Influential?
(Suggest an Edit or Addition)Eldad Melamed's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- VPS35 mutations in Parkinson disease. (2011) (784)
- Oxidative stress induced-neurodegenerative diseases: the need for antioxidants that penetrate the blood brain barrier (2001) (755)
- Precursor control of neurotransmitter synthesis. (1980) (666)
- The role of oxidative stress in the pathogenesis of multiple sclerosis: The need for effective antioxidant therapy (2004) (585)
- Rasagiline as an adjunct to levodopa in patients with Parkinson's disease and motor fluctuations (LARGO, Lasting effect in Adjunct therapy with Rasagiline Given Once daily, study): a randomised, double-blind, parallel-group trial (2005) (563)
- Antioxidant Therapy in Acute Central Nervous System Injury: Current State (2002) (559)
- A double-blind, delayed-start trial of rasagiline in Parkinson's disease. (2009) (526)
- Partial lesions of the dopaminergic nigrostriatal system in rat brain: biochemical characterization (1980) (514)
- The natural history of multiple system atrophy: a prospective European cohort study (2013) (376)
- Levodopa in the treatment of Parkinson's disease: Current controversies (2004) (370)
- Validation of the freezing of gait questionnaire in patients with Parkinson's disease (2009) (332)
- Reduction in Regional Cerebral Blood Flow During Normal Aging in Man (1980) (326)
- The “Dying-Back” Phenomenon of Motor Neurons in ALS (2011) (324)
- The mystery of motor asymmetry in Parkinson's disease (2006) (300)
- Quantitative measurement of pain sensation in patients with Parkinson disease (2004) (269)
- Prevention of Dopamine-Induced Cell Death by Thiol Antioxidants: Possible Implications for Treatment of Parkinson's Disease (1996) (256)
- Stimulation of nigrostriatal dopamine neurones by nicotine (1982) (242)
- Dopamine induces apoptosis-like cell death in cultured chick sympathetic neurons — A possible novel pathogenetic mechanism in Parkinson's disease (1994) (235)
- Safety and Clinical Effects of Mesenchymal Stem Cells Secreting Neurotrophic Factor Transplantation in Patients With Amyotrophic Lateral Sclerosis: Results of Phase 1/2 and 2a Clinical Trials. (2016) (228)
- Camptocormia (bent spine) in patients with Parkinson's disease—Characterization and possible pathogenesis of an unusual phenomenon (1999) (227)
- Transgenic mice expressing human Bcl-2 in their neurons are resistant to 6-hydroxydopamine and 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine neurotoxicity. (1998) (227)
- Circling behavior in rats with partial, unilateral nigro-striatal lesions: Effect of amphetamine, apomorphine, and DOPA (1980) (226)
- Increased Plasma Endothelin‐1 in Acute Ischemic Stroke (1992) (225)
- NEUROTRANSMITTERS AND THE FIFTH CRANIAL NERVE: IS THERE A RELATION TO THE HEADACHE PHASE OF MIGRAINE? (1979) (208)
- A double-blind, delayed-start trial of rasagiline in Parkinson's disease (the ADAGIO study): prespecified and post-hoc analyses of the need for additional therapies, changes in UPDRS scores, and non-motor outcomes (2011) (207)
- Gastric emptying in Parkinson's disease (1996) (200)
- Reactive hyperglycaemia in patients with acute stroke (1976) (189)
- The site of dopamine formation in rat striatum after L-dopa administration. (1981) (180)
- Nonaminergic striatal neurons convert exogenous l‐dopa to dopamine in parkinsonism (1980) (180)
- Human mesenchymal stem cells express neural genes, suggesting a neural predisposition. (2006) (177)
- Psychosis in advanced Parkinson's disease (1995) (174)
- Rasagiline Mesylate, a New Mao-B Inhibitor for the Treatment of Parkinson's Disease: A Double-Blind Study as Adjunctive Therapy to Levodopa (2000) (168)
- Semaphorins as Mediators of Neuronal Apoptosis (1999) (165)
- Apoptosis and Parkinson's disease (2003) (165)
- A randomized, double‐blind, placebo‐controlled, delayed start study to assess rasagiline as a disease modifying therapy in Parkinson's disease (the ADAGIO study): Rationale, design, and baseline characteristics (2008) (158)
- Molecular mechanisms of selective dopaminergic neuronal death in Parkinson's disease. (2003) (151)
- Protective effects of neurotrophic factor-secreting cells in a 6-OHDA rat model of Parkinson disease. (2009) (148)
- Increased survival and migration of engrafted mesenchymal bone marrow stem cells in 6-hydroxydopamine-lesioned rodents (2006) (147)
- Long‐term administration of L‐DOPA does not damage dopaminergic neurons in the mouse (1981) (142)
- Enhanced Oxidative Stress and Altered Antioxidants in Brains of Bcl‐2‐Deficient Mice (1998) (140)
- Oxidative insults induce DJ-1 upregulation and redistribution: implications for neuroprotection. (2008) (136)
- Effect of Chronic Atrial Fibrillation on Regional Cerebral Blood Flow (1980) (132)
- Intravitreal injections of neurotrophic factors secreting mesenchymal stem cells are neuroprotective in rat eyes following optic nerve transection. (2010) (128)
- [123I]‐FP/CIT SPECT imaging for distinguishing drug‐induced parkinsonism from Parkinson's disease (2006) (125)
- Dopamine-induced programmed cell death in mouse thymocytes. (1995) (123)
- Clinicogenetic study of mutations in LRRK2 exon 41 in Parkinson's disease patients from 18 countries (2006) (122)
- Regenerative effect of neural-induced human mesenchymal stromal cells in rat models of Parkinson's disease. (2008) (122)
- Glutaredoxin Protects Cerebellar Granule Neurons from Dopamine-induced Apoptosis by Activating NF-κB via Ref-1* (2001) (121)
- Vasoactive intestinal peptide (VIP) prevents neurotoxicity in neuronal cultures: relevance to neuroprotection in Parkinson's disease 1 This manuscript is based on a poster presented at the Brain Research Interactive Symposium on “Neuropeptides at the Millennium”, Miami, October 1999. 1 (2000) (119)
- Antioxidant treatment in alzheimer’s disease (2003) (116)
- Early-morning dystonia. A late side effect of long-term levodopa therapy in Parkinson's disease. (1979) (112)
- Parkinson Psychosis Rating Scale: a practical instrument for grading psychosis in Parkinson's disease. (1998) (112)
- The Effect of Acute Stroke on Cardiac Functions as Observed in an Intensive Stroke Care Unit (1974) (109)
- Introducing Transcription Factors to Multipotent Mesenchymal Stem Cells: Making Transdifferentiation Possible (2009) (108)
- Anti-semaphorin 3A Antibodies Rescue Retinal Ganglion Cells from Cell Death following Optic Nerve Axotomy* (2002) (108)
- Intravenous immunoglobulin treatment of experimental T cell-mediated autoimmune disease. Upregulation of T cell proliferation and downregulation of tumor necrosis factor alpha secretion. (1994) (108)
- A low molecular weight copper chelator crosses the blood–brain barrier and attenuates experimental autoimmune encephalomyelitis (2004) (107)
- Bone-marrow-derived mesenchymal stem cell therapy for neurodegenerative diseases (2009) (107)
- The Etiopathogenesis of Parkinson Disease and Suggestions for Future Research. Part II (2007) (106)
- Partial lesions of the nigrostriatal pathway in the rat Acceleration of transmitter synthesis and release of surviving dopaminergic neurones by drugs (1985) (106)
- Riluzole suppresses experimental autoimmune encephalomyelitis: implications for the treatment of multiple sclerosis (2003) (104)
- DJ-1 protects against dopamine toxicity (2009) (103)
- Consensus statement on the role of acute dopaminergic challenge in Parkinson's disease (2001) (102)
- Skin biopsy for assessment of autonomic denervation in Parkinson’s disease (2006) (97)
- Induction of human mesenchymal stem cells into dopamine-producing cells with different differentiation protocols. (2008) (96)
- Dopamine–melanin induces apoptosis in PC12 cells; possible implications for the etiology of Parkinson's disease (1997) (96)
- The Prognostic Value of the CT Scan in Conservatively Treated Patients With Intracerebral Hematoma (1984) (95)
- 123I-FP-CIT SPECT imaging of dopamine transporters in patients with cerebrovascular disease and clinical diagnosis of vascular parkinsonism. (2004) (94)
- Episodic unresponsiveness to single doses of L‐dopa in parkinsonian fluctuators (1986) (93)
- Tyrosine administration increases striatal dopamine release in rats with partial nigrostriatal lesions. (1980) (93)
- Levodopa induces apoptosis in cultured neuronal cells—A possible accelerator of nigrostriatal degeneration in Parkinson's disease? (1997) (93)
- Paroxysmal dystonia as the initial manifestation of multiple sclerosis. (1984) (92)
- Open controlled therapeutic trial of intravenous immune globulin in relapsing-remitting multiple sclerosis. (1992) (91)
- Levodopa in the treatment of Parkinson's disease: A consensus meeting viewpoint (1999) (90)
- The Effect of Duloxetine on Primary Pain Symptoms in Parkinson Disease (2007) (90)
- Cortical activation pattern during saccadic eye movements in humans: Localization by focal cerebral blood flow increases (1979) (87)
- Fatigue in multiple sclerosis compared with chronic fatigue syndrome (1996) (87)
- Effects of oral L-tyrosine administration on CSF tyrosine and homovanillic acid levels in patients with Parkinson's disease. (1982) (87)
- Primary progressive freezing gait (2020) (87)
- Induction of Adult Human Bone Marrow Mesenchymal Stromal Cells into Functional Astrocyte-Like Cells: Potential for Restorative Treatment in Parkinson’s Disease (2009) (86)
- Spinal Cord mRNA Profile in Patients with ALS: Comparison with Transgenic Mice Expressing the Human SOD-1 Mutant (2009) (86)
- Wnt Signaling Enhances Neurogenesis and Improves Neurological Function after Focal Ischemic Injury (2012) (85)
- Mesenchymal Stem Cells Stimulate Endogenous Neurogenesis in the Subventricular Zone of Adult Mice (2011) (84)
- Enhanced fatigue during motor performance in patients with Parkinson's disease (1998) (83)
- Glutaredoxin Protects Cerebellar Granule Neurons from Dopamine-induced Apoptosis by Dual Activation of the Ras-Phosphoinositide 3-Kinase and Jun N-terminal Kinase Pathways* (2001) (82)
- Paraventricular nucleus serotonin mediates neurally stimulated adrenocortical secretion (1987) (82)
- Mutant and wild-type α-synuclein interact with mitochondrial cytochrome C oxidase (2002) (82)
- Ondansetron for hallucinosis in advanced Parkinson's disease (1993) (81)
- Activation of nuclear transcription factor kappa B (NF‐κB) is essential for dopamine‐induced apoptosis in PC12 cells (2001) (81)
- Migration of Neurotrophic Factors‐Secreting Mesenchymal Stem Cells Toward a Quinolinic Acid Lesion as Viewed by Magnetic Resonance Imaging (2008) (80)
- Intravenous immunoglobulin treatment in multiple sclerosis. (1999) (80)
- Initiation of levodopa therapy in parkinsonian patients should be delayed until the advanced stages of the disease. (1986) (80)
- Aromatic L‐amino acid decarboxylase in rat corpus striatum (1981) (80)
- The synthesis of prostaglandins by bovine cerebral microvessels. (1980) (77)
- Forms of dystonia in patients with Parkinson's disease (1987) (77)
- The Effect of Cerebral Infarction on the Regional Cerebral Blood Flow of the Contralateral Hemisphere (1975) (76)
- The Etiopathogenesis of Parkinson Disease and Suggestions for Future Research. Part I (2007) (75)
- Dopamine but not norepinephrine or serotonin uptake inhibitors protect mice against neurotoxicity of MPTP. (1985) (73)
- Haloperidol – induced neurotoxicity – possible implications for tardive dyskinesia (2000) (72)
- Transplantation of Placenta-Derived Mesenchymal Stem Cells in the EAE Mouse Model of MS (2012) (71)
- Systemic administration of antioxidants does not protect mice against the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine (MPTP) (1986) (71)
- Brain neurotransmitter profile is deranged during sepsis and septic encephalopathy in the rat. (1985) (71)
- Intracerebroventricular Transplantation of Human Mesenchymal Stem Cells Induced to Secrete Neurotrophic Factors Attenuates Clinical Symptoms in a Mouse Model of Multiple Sclerosis (2010) (70)
- Is There a Rationale for Neuroprotection Against Dopamine Toxicity in Parkinson's Disease? (2001) (70)
- Mesenchymal stem cells induced to secrete neurotrophic factors attenuate quinolinic acid toxicity: A potential therapy for Huntington's disease (2012) (70)
- Levodopa Toxicity and Apoptosis (1998) (69)
- Mapping of human cerebral functions: a study of the regional cerebral blood flow pattern during rest, its reproducibility and the activations seen during basic sensory and motor functions. (1977) (67)
- Neurogenesis in the aged and neurodegenerative brain (2010) (66)
- Diagnosis of “non-organic” limb paresis by a novel objective motor assessment: the quantitative Hoover’s test (1998) (66)
- Docosahexaenoic acid and arachidonic acid are fundamental supplements for the induction of neuronal differentiation Published, JLR Papers in Press, December 21, 2006. (2007) (65)
- Differentiated Mesenchymal Stem Cells for Sciatic Nerve Injury (2011) (65)
- Handedness as a predictor of side of onset of Parkinson's disease. (2008) (65)
- Therapeutic Potential of Neurotrophic Factors in Neurodegenerative Diseases (2012) (62)
- Cerebral blood flow and cognitive impairment in Parkinson's disease (1985) (62)
- A novel thiol antioxidant that crosses the blood brain barrier protects dopaminergic neurons in experimental models of Parkinson's disease (2005) (62)
- Elevation of plasma tyrosine after a single oral dose of L-tyrosine. (1979) (62)
- Persistent and progressive parkinsonism after discontinuation of chronic neuroleptic therapy: an additional tardive syndrome? (1991) (62)
- Intrastriatal transplantation of mouse bone marrow-derived stem cells improves motor behavior in a mouse model of Parkinson's disease. (2007) (62)
- Lesions outside the CNS in Parkinson's disease (2009) (62)
- 6-Hydroxydopamine Increases Ubiquitin-Conjugates and Protein Degradation: Implications for the Pathogenesis of Parkinson's Disease (2001) (61)
- Role of DJ-1 in Parkinson's disease (2007) (61)
- Knocking Out DJ-1 Attenuates Astrocytes Neuroprotection Against 6-Hydroxydopamine Toxicity (2013) (60)
- Interictal regional cerebral blood flow in patients with partial seizures (1976) (60)
- Autotransplantation of bone marrow-derived stem cells as a therapy for neurodegenerative diseases. (2007) (59)
- Effect of deep brain subthalamic stimulation on camptocormia and postural abnormalities in idiopathic Parkinson's disease (2006) (59)
- Lentiviral delivery of LMX1a enhances dopaminergic phenotype in differentiated human bone marrow mesenchymal stem cells. (2009) (59)
- Integral therapeutic potential of bone marrow mesenchymal stem cells. (2005) (58)
- Serotonergic neurones are not involved in action of L-dopa in Parkinson's disease (1980) (57)
- Bihemispheric decreases of regional cerebral blood flow in dementia: Correlation with age‐matched normal controls (1978) (57)
- Trial designs used to study neuroprotective therapy in Parkinson's disease (2013) (57)
- Effect of cisapride on response fluctuations in Parkinson's disease (1995) (57)
- Riluzole for le vodopa-induced dyskinesias in advanced P arkinson's disease (1999) (56)
- Apoptosis as a general cell death pathway in neurodegenerative diseases. (2000) (56)
- Involvement of serotonin in clinical features of Parkinson's disease and complications of L-DOPA therapy. (1996) (54)
- Direct localisation of β-adrenoceptor sites in rat cerebellum by a new fluorescent analogue of propranolol (1976) (54)
- The assessment of changes in brain volume using combined linear measurements (2004) (54)
- Embryonic and adult stem cells as a source for cell therapy in Parkinson’s disease (2007) (54)
- Contribution of genetic variants to pain susceptibility in Parkinson disease (2012) (53)
- Dopaminergic differentiation of human mesenchymal stem cells—Utilization of bioassay for tyrosine hydroxylase expression (2007) (52)
- l-DOPA's mechanism of action in Parkinson's disease (1980) (51)
- Mutant and wild-type alpha-synuclein interact with mitochondrial cytochrome C oxidase. (2002) (50)
- Induction of neuron-specific enolase promoter and neuronal markers in differentiated mouse bone marrow stromal cells (2007) (50)
- Anti-inflammatory drugs in the treatment of neurodegenerative diseases: current state. (2006) (49)
- DJ-1 protects against dopamine toxicity: implications for Parkinson's disease and aging. (2013) (49)
- Aphasia in multiple sclerosis (1992) (48)
- Familial Parkinsonism with digenic parkin and PINK1 mutations (2008) (48)
- Tardive dyskinesia associated with metoclopramide. (1978) (48)
- Norepinephrine depletion in the paraventricular nucleus inhibits the adrenocortical responses to neural stimuli (1986) (47)
- The molecular mechanism of dopamine-induced apoptosis: identification and characterization of genes that mediate dopamine toxicity. (2000) (47)
- Adult neurotrophic factor-secreting stem cells: a potential novel therapy for neurodegenerative diseases. (2009) (47)
- Hypertension and Diabetes as Risk Factors in Stroke Patients (1973) (47)
- Hemiballismus: Detection of focal hemorrhage in subthalamic nucleus by ct scan (1978) (47)
- Dopamine-Induced Apoptosis Is Inhibited in PC12 Cells Expressing Bcl-2 (1997) (47)
- Two Waves of Cyclin B and Proliferating Cell Nuclear Antigen Expression During Dopamine‐Triggered Neuronal Apoptosis (1997) (46)
- Dopamine release in rat striatum after administration ofl-DOPA as studied with in vivo electrochemistry (1981) (45)
- Induction of neuronal apoptosis by Semaphorin3A-derived peptide. (2000) (44)
- Early‐occurrence of manual motor blocks in Parkinson's disease: a quantitative assessment (1999) (44)
- Suppression of L‐dopa‐induced circling in rats with nigral lesions by blockade of central dopa‐decarboxylase (1984) (44)
- Stem cells treatment for sciatic nerve injury (2011) (43)
- DJ-1 Changes in G93A-SOD1 Transgenic Mice: Implications for Oxidative Stress in ALS (2009) (43)
- Wnt signaling pathway overcomes the disruption of neuronal differentiation of neural progenitor cells induced by oligomeric amyloid β‐peptide (2011) (43)
- Camptocormia in Parkinson’s disease (2006) (43)
- Proteasomal inhibition hypersensitizes differentiated neuroblastoma cells to oxidative damage (2006) (43)
- Levodopa ethylester : A novel rescue therapy for response fluctuations in parkinson's disease (1996) (42)
- Oxidative stress, induced by 6-hydroxydopamine, reduces proteasome activities in PC12 cells (2007) (41)
- Light activation of dopaminergic neurons in rat retina is mediated through photoreceptors (1982) (41)
- Mesolimbic dopaminergic neurons are not spared by MPTP neurotoxicity in mice. (1985) (41)
- Comparative characterization of bone marrow-derived mesenchymal stromal cells from four different rat strains. (2009) (40)
- β-adrenergic receptors in rat cerebral cortex: histochemical localization by a fluorescent β-blocker (1977) (40)
- Psychosis: impact on the patient and family. (1999) (40)
- Novel molecular imaging of cell death in experimental cerebral stroke (2007) (39)
- Effect of ischemia induced by middle cerebral artery occlusion on superoxide dismutase activity in rat brain. (1990) (39)
- Levodopa – an exotoxin or a therapeutic drug? (2000) (39)
- In vivo effect of MPTP on monoamine oxidase activity in mouse striatum (1985) (39)
- Huntington chorea is not associated with hyperactivity of nigrostriatal dopaminergic neurons (1982) (38)
- Regional cerebral blood flow in patients with Parkinson's disease. (1979) (38)
- [123I]-FP-CIT SPECT and olfaction test in patients with combined postural and rest tremor (2008) (38)
- Oxidative stress and neuroprotection in Parkinson's disease: implications from studies on dopamine-induced apoptosis. (1999) (38)
- Conjugate eye deviation after acute hemispheric stroke: Delayed recovery after previous contralateral frontal lobe damage (1984) (38)
- A DJ-1 Based Peptide Attenuates Dopaminergic Degeneration in Mice Models of Parkinson's Disease via Enhancing Nrf2 (2015) (37)
- Role of DJ-1 in parkinson’s disease (2007) (37)
- The Involvement of p53 in Dopamine-Induced Apoptosis of Cerebellar Granule Neurons and Leukemic Cells Overexpressing p53 (1999) (37)
- Dopamine-melanin is actively phagocytized by PC12 cells and cerebellar granular cells: possible implications for the etiology of Parkinson's disease (1999) (36)
- Involvement of ventral noradrenergic bundle in corticosterone secretion following neural stimuli (1988) (36)
- Mechanism of action of short- and long-term L-DOPA treatment in parkinsonism: role of the surviving nigrostriatal dopaminergic neurons. (1984) (35)
- Suppression of MPTP-induced dopaminergic neurotoxicity in mice by nomifensine andl-DOPA (1985) (35)
- Late-onset progressive radiculomyelopathy in patients with cervical athetoid-dystonic cerebral palsy. (1987) (34)
- Delayed onset of responses to single doses of L-dopa in parkinsonian fluctuators on long-term L-dopa therapy. (1986) (34)
- Hemin-induced apoptosis in PC12 and neuroblastoma cells: Implications for local neuronal death associated with intracerebral hemorrhage (2009) (34)
- Waiting for ON: A Major Problem in Patients With Parkinson Disease and ON/OFF Motor Fluctuations (2003) (34)
- Spastic paraparesis associated with human T‐lymphotropic virus type I: A clinical, serological, and genomic study in Iranian‐born Mashhadi Jews (1993) (34)
- Impaired absorption of oral levodopa: a major cause for response fluctuations in Parkinson's disease. (1996) (33)
- Ondansetron, a 5-HT3 antagonist for visual hallucinations and paranoid delusional disorder associated with chronic L-DOPA therapy in advanced Parkinson's disease. (1996) (33)
- Camptocormia in Parkinson’s disease: new insights (2006) (33)
- Correlation between regional cerebral blood flow and EEG frequency in the contralateral hemisphere in acute cerebral infarction (1975) (33)
- Histochemical evidence for β-adrenergic receptors in the rat spinal cord (1976) (33)
- Is there addiction to levodopa in patients with Parkinson's disease? (2000) (33)
- Oral solution of levodopa ethylester for treatment of response fluctuations in patients with advanced Parkinson's disease (2002) (33)
- Cell replacement therapy for Parkinson’s disease: how close are we to the clinic? (2011) (32)
- Patient and caregiver perceptions of the social impact of advanced Parkinson’s disease and dyskinesias (2012) (32)
- Chronic L‐dopa administration decreases striatal accumulation of dopamine from exogenous L‐dopa in rats with intact nigrostriatal projections (1983) (32)
- Polymorphism in candidate genes: implications for the risk and treatment of idiopathic Parkinson's disease (2004) (32)
- Correlation between regional cerebral blood flow and brain atrophy in dementia. Combined study with 133Xenon inhalation and computerised tomography. (1978) (32)
- Hemispheric brain damage in unilateral status epilepticus (1986) (32)
- Management of motor complications in advanced Parkinson's disease (2007) (31)
- Riluzole for levodopa-induced dyskinesias in advanced Parkinson's disease. (1999) (31)
- Experimental encephalomyelitis induces changes in DJ-1: implications for oxidative stress in multiple sclerosis. (2006) (31)
- Nigrostriatal neuronal death in Parkinson's disease--a passive or an active genetically-controlled process? (1997) (31)
- Decarboxylation of exogenous L-DOPA in rat striatum after lesions of the dopaminergic nigrostriatal neurons: the role of striatal capillaries (1980) (31)
- Acute “upside down” reversal of vision in transient vertebrobasilar ischemia (1987) (30)
- Dopamine turnover in rat retina: A 24-hour light-dependent rhythm (1984) (30)
- Residual striatal dopaminergic nerve terminals in very long‐standing Parkinson's disease: A single photon emission computed tomography imaging study (2011) (30)
- The molecular mechanisms of dopamine toxicity. (2003) (30)
- The CB1 cannabinoid receptor agonist, HU-210, reduces levodopa-induced rotations in 6-hydroxydopamine-lesioned rats. (2003) (30)
- Monoamine-Induced Apoptotic Neuronal Cell Death (1997) (30)
- High prevalence of malignant melanoma in Israeli patients with Parkinson’s disease (2011) (29)
- Reversible central nervous system dysfunction in folate deficiency (1975) (29)
- Dissociation of the effects of castration and testosterone replacement on sexual behavior and neural metabolism of dopamine in the male rat (1986) (29)
- l‐3, 4‐Dihydroxyphenylalanine and l‐5‐Hydroxytryptophan Decarboxylase Activities in Rat Striatum: Effect of Selective Destruction of Dopaminergic or Serotoninergic Input (1980) (28)
- Role of apoptosis in the pathogenesis of Parkinson's disease: A novel therapeutic opportunity? (1998) (28)
- beta-Adrenergic receptors in rat kidney: direct localization by a fluorescent beta-blocker. (1977) (28)
- Expression of Cell Cycle-Related Genes During Neuronal Apoptosis: Is there a Distinct Pattern? (1998) (28)
- Direct mapping of β-adrenergic receptors in the rat central nervous system by a novel fluorescent β-blocker (1978) (28)
- Intrastriatal transplantation of neurotrophic factor-secreting human mesenchymal stem cells improves motor function and extends survival in R6/2 transgenic mouse model for Huntington's disease (2012) (28)
- Induction of mitosis-related genes during dopamine-triggered apoptosis in sympathetic neurons. (1997) (27)
- Current management of motor fluctuations in patients with advanced Parkinson's disease treated chronically with levodopa. (1999) (27)
- Harnessing neurogenesis for the possible treatment of Parkinson's disease (2014) (27)
- Antibodies from ALS patients inhibit dopamine release mediated by L-type calcium channels (1998) (27)
- Effect of central serotonin depletion on adrenocortical responses to neural stimuli (1984) (27)
- Hippocampal cell nuclear binding of corticosterone following 5,7-dihydroxytryptamine (1983) (26)
- The decarboxylation of DOPA in the parkinsonian brain: in vivo studies on an animal model. (1980) (26)
- Intravenous gammaglobulin treatment in multiple sclerosis and experimental autoimmune encephalomyelitis: delineation of usage and mode of action. (1994) (26)
- Bent knees and tiptoeing: Late manifestations of end‐stage Parkinson's disease (2004) (26)
- Regional cerebral blood flow during voluntary conjugate eye movements in man. (1977) (25)
- Cerebral sinus thrombosis as a potential hazard of antifibrinolytic treatment in menorrhagia. (1990) (25)
- Modulation of control mechanisms of dopamine-induced apoptosis--a future approach to the treatment of Parkinson's disease? (1997) (25)
- NON-INVASIVE QUANTITATION OF CORNEAL COPPER IN HEPATOLENTICULAR DEGENERATION (WILSON'S DISEASE) (1976) (25)
- Diminished decarboxylation of l-dopa in rat striatum after intrastriatal injections of kainic acid (1980) (25)
- Intracerebral adult stem cells transplantation increases brain-derived neurotrophic factor levels and protects against phencyclidine-induced social deficit in mice (2011) (25)
- Mice overexpressing Bcl-2 in their neurons are resistant to myelin oligodendrocyte glycoprotein (MOG)-induced experimental autoimmune encephalomyelitis (EAE) (2000) (24)
- New therapies for Parkinson's disease (2001) (24)
- Management of response fluctuations (1998) (24)
- Letter: Posterolateral myelopathy associated with thyrotoxicosis. (1975) (24)
- Immunity of Fetal Mice to Prenatal Administration of the Dopaminergic Neurotoxin 1‐Methyl‐4‐Phenyl‐1,2,3,6‐Tetrahydropyridine (1990) (24)
- A Novel Brain-Targeted Antioxidant (AD4) Attenuates Haloperidol-Induced Abnormal Movement in Rats:: Implications for Tardive Dyskinesia (2005) (24)
- Regional cerebral blood flow in parkinsonism Measurement before and after levodopa (1978) (23)
- Localization of beta receptors in the anterior segment of the rat eye by a fluorescent analogue of propranolol. (1978) (23)
- Leptomeningeal metastases: Reduction in regional cerebral blood flow and cognitive impairment (1985) (23)
- Regional Cerebral Blood Flow Response to Hypocapnia in the Contralateral Hemisphere of Patients With Acute Cerebral Infarction (1975) (23)
- Placental mesenchymal stromal cells induced into neurotrophic factor-producing cells protect neuronal cells from hypoxia and oxidative stress. (2012) (23)
- Stem cell grafting in parkinsonism--why, how and when. (2014) (23)
- Hypothalamic norepinephrine mediates limbic effects on adrenocortical secretion (1988) (23)
- Compensatory mechanisms in the nigrostriatal dopaminergic system in Parkinson's disease: studies in an animal model. (1982) (22)
- Developmental changes in antioxidant enzymes and oxidative damage in kidneys, liver and brain of bcl-2 knockout mice. (2000) (22)
- Bax-ablation attenuates experimental autoimmune encephalomyelitis in mice (2004) (22)
- Analysis of gene expression in MOG-induced experimental autoimmune encephalomyelitis after treatment with a novel brain-penetrating antioxidant (2007) (22)
- Abnormal skin wrinkling in the less affected side in hemiparkinsonism-a possible test for sympathetic dysfunction in Parkinson's disease. (2001) (22)
- Effect of dopamine agonists on fatigue and somnolence in Parkinson's disease (2006) (22)
- Amphetamine, but not reserpine, protects mice against dopaminergic neurotoxicity of MPTP (1985) (21)
- New drugs in the future treatment of Parkinson's disease (2002) (21)
- Recent advances in amyotrophic lateral sclerosis research: perspectives for personalized clinical application (2010) (21)
- Focal dystonia as the presenting sign in Creutzfeldt‐Jakob disease (2002) (20)
- Stroke in Jerusalem District 1960 Through 1967: An Epidemiological Study (1973) (20)
- PARKINSONISM ASSOCIATED WITH CHRONIC INHALATION OF CARBON TETRACHLORIDE (1977) (19)
- Pharmacokinetics of Etilevodopa Compared to Levodopa in Patient's With Parkinson's Disease: An Open-label, Randomized, Crossover Study (2003) (19)
- Clinical characteristics of Parkinson’s disease among Jewish Ethnic groups in Israel (2008) (19)
- Human T‐cell lymphotropic virus type I in Iranian‐born Mashhadi Jews: Genetic and phylogenetic evidence for common source of infection (1995) (18)
- Perspective: Identification of genetic variants associated with dopaminergic compensatory mechanisms in early Parkinson's disease (2013) (18)
- Dementia and myoclonus in a case of cryptococcal encephalitis. (1984) (18)
- Localization of beta-andrenoceptors in the anterior segment of the albino rabbit eye using a fluorescent analog of propranolol. (1979) (18)
- The regional cerebral blood flow in patients under chronic hemodialytic treatment. (1987) (17)
- Taking sides: Is handedness involved in motor asymmetry of Parkinson's disease? (2012) (17)
- Adult stem cells for neuronal repair. (2006) (17)
- Dopamine-induced, genotoxic activation of programmed cell death. A role in nigrostriatal neuronal degeneration in Parkinson's disease? (1996) (17)
- Role of medial forebrain bundle catecholaminergic fibers in the modulation of glucocorticoid negative feedback effects (1983) (17)
- Rare combination of myasthenia and motor neuronopathy, responsive to Msc‐Ntf stem cell therapy (2014) (16)
- Short-term beneficial effect of deprenyl monotherapy in early Parkinson's disease: a quantitative assessment. (1993) (16)
- Neuroprotection in progressive brain disorders. (2003) (16)
- Prognostic value of visual evoked potentials in occipital blindness following basilar artery occlusion. (1975) (16)
- Features of brain atrophy in Parkinson's disease (1985) (16)
- Use of a single [123I]-FP-CIT SPECT to predict the severity of clinical symptoms of Parkinson disease (2009) (16)
- Reduction in regional cerebral blood flow during normal aging is not limited to elderly subjects. (1984) (15)
- Effect of serotonergic, corticostriatal and kainic acid lesions on the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6- tetrahydropyridine (MPTP) in mice (1986) (15)
- Regional cerebral blood flow in down's syndrome (1987) (15)
- Progressive brain atrophy during normal aging in man: a quantitative computerized tomography study. (1985) (15)
- Levodopa therapy can ameliorate tetrabenazine‐induced parkinsonism (1999) (15)
- Diphenylhydantoin and phenobarbital suppress the dopaminergic neurotoxicity of MPTP in mice. (1986) (15)
- Effect of subcutaneous administration of levodopa ethyl ester, a soluble prodrug of levodopa, on dopamine metabolism in rodent striatum: implication for treatment of Parkinson's disease. (1996) (15)
- Catechol-O-Methyltransferase Decreases Levodopa Toxicity In Vitro (2001) (14)
- Prevention of dopaminergic toxicity of MPTP in mice by phenylethylamine, a specific substrate of type B monoamine oxidase (1985) (14)
- Effect of postnatal light deprivation on the ontogenesis of dopamine neurons in rat retina. (1986) (14)
- Beneficial effect of levodopa therapy on stooped posture in Parkinson's disease. (2015) (14)
- The role of neurotransmitters and neuropeptides in Parkinson's disease: implications for therapy (2004) (14)
- Adrenocortical responses to ether stress and neural stimuli in rats following the injection of 6-hydroxydopamine into the medial forebrain bundle (1984) (13)
- The proto-oncogene Bcl-2 inhibits cellular toxicity of dopamine: possible implications for Parkinson's Disease (2004) (13)
- Primary postural instability: a cause of recurrent sudden falls in the elderly (2006) (13)
- Detection and measurement of an endogenous clonidine-displacing substance in human cerebrospinal fluid (1993) (13)
- Levels of some organochlorine residues in blood of patients with arteriosclerotic disease. (1986) (13)
- Interactions of exogenous L-dopa with nigrostriatal dopaminergic neurons in Parkinson's disease. (1990) (12)
- Therapeutic Effect of Myogenic Cells Modified to Express Neurotrophic Factors in a Rat Model of Sciatic Nerve Injury (2012) (12)
- Unilateral lower limb rest tremor is not necessarily a presenting symptom of Parkinson's disease (2010) (12)
- Inhibition in corticotrophin and corticosterone secretion following photic stimulation in rats with 6‐hydroxydopamine injection into the medial forebrain bundle (1984) (12)
- Regional cerebral blood flow in patients with Parkinson's disease under chronic levodopa therapy: measurements during "on" and "off" response fluctuations. (1986) (11)
- Differential effect of acute and chronic haloperidol administration on dopamine turnover in rat nigrostriatal and retinal dopaminergic neurons. (1983) (11)
- Studies on brain monoamine neurotransmitters in mice after prenatal exposure to barbiturate (1985) (11)
- Tardive dyskinesia induced by sulpiride. (1990) (11)
- The regional cerebral blood flow in familial dysautonomia (1989) (11)
- Hyperparathyroidism presenting with unusual neurological features. (1979) (11)
- Dyskinesias assessment workshop: reports from the working groups. (1999) (10)
- Longitudinal MRI and MRSI characterization of the quinolinic acid rat model for excitotoxicity: peculiar apparent diffusion coefficients and recovery of N‐acetyl aspartate levels (2010) (10)
- Reply from Hefti and Melamed (1981) (10)
- Acarbose reduces blood pressure in sucrose-induced hypertension in rats. (1997) (10)
- Respiratory distress: an unrecognized non-motor phenomenon in patients with parkinsonism (2011) (10)
- Tardive eating dystonia (1990) (10)
- The dopaminergic amacrine system and its response to light stimulation in rats with inherited retinal dystrophy. (1984) (10)
- Direct Evidence for Absence of Beta‐Adrenergic Receptors in Rat Cerebral Vessels Histochemical Study with a Fluorescent Beta‐Blocker (1977) (10)
- Folic acid and the nervous system (1983) (10)
- Progressive age-related decrease in regional cerebral blood flow in healthy subjects. (1985) (9)
- Cortical blindness as a manifestation of basilar artery occlusion. (1974) (9)
- Effect of subcutaneous apomorphine on tremor in idiopathic Parkinson's disease. (2008) (9)
- Plasma tyrosine in normal humans: Effects of oral tyrosine and protein-containing meals (2005) (9)
- Synthesis, binding affinity, and relaxivity of target-specific MRI contrast agents (2007) (9)
- Role of the nigrostriatal dopaminergic neurons in mediating the effect of exogenous L-dopa in Parkinson's disease. (1988) (9)
- Effect of electrical stimulation of nigrostriatal dopaminergic neurons on utilization of exogenous L‐dopa in rat corpus striatum (1982) (9)
- First emergence of “delayed‐on” and “dose failure” phenomena in a patient with Parkinson's disease following vagotomy (1994) (8)
- Coexistence of severe parkinsonism and tardive dyskinesia as side effects of neuroleptic therapy. (1984) (8)
- Central nervous system complication in a patient with chronic gaucher's disease. (1975) (8)
- Editorial: apoptosis in the aging brain (2010) (7)
- Patterns of Cognitive Impairment in Patients with Alzheimer’s Disease and Parkinson’s Disease: Are They Similar or Different? (1986) (7)
- Brain grafting may reverse loss of responsiveness to levodopa therapy in Parkinson's disease. (1988) (7)
- Biochemical and functional differences between dopamine formed from endogenous tyrosine and exogenous L-dopa in nigrostriatal dopaminergic neurons (1992) (7)
- Immediate spasticity with acute hemiplegia is a sign of basal ganglia hemorrhage (1985) (7)
- HTL V-I from Iranian Mashhadi Jews in Israel is phylogenetically related to that of Japan, India, and South America rather than to that of Africa and Melanesia (2005) (7)
- Breaking bad news and personality assessment. (2000) (7)
- INTRAVENOUS IMMUNOGLOBULIN TREATMENT IN MULTIPLE SCLEROSIS. AUTHORS' REPLY (1999) (7)
- Involvement of T-complex Protein-1δ in Dopamine Triggered Apoptosis in Chick Embryo Sympathetic Neurons* (2000) (7)
- Acute transitory cerebellar dysfunction associated with piperazine adipate. (1979) (6)
- Direct mapping of beta-adrenergic receptors in the rat central nervous system by a novel fluorescent beta-blocker. (1978) (6)
- Early and delayed neurotoxicity of Mitoxantrone and Doxorubicin following subarachnoid injection (1988) (6)
- Regional cerebral blood flow in the epileptic brain during the seizure-free interval. (1977) (6)
- Initiation of symptomatic therapy in Parkinson's disease: dopamine agonists versus levodopa (2007) (6)
- The effect of deprenyl washout in patients with long-standing Parkinson's disease (2002) (6)
- Beta-adrenergic receptors in rat myocardium: Direct detection by a new fluorescent beta-blocker (1976) (6)
- The Pharmacokinetic Profile of the “First Ever” Oral Dose of Levodopa in De Novo Patients with Parkinson's Disease (2001) (6)
- Long-term Parkinson's disease--time for optimism. (2008) (6)
- The role of functional neurosurgery in Parkinson's disease. (2000) (5)
- The neurotoxin MPTP does not affect striatal superoxide dismutase activity in mice (1987) (5)
- Open controlled therapeutic trial of intravenous immunoglobulins in relapsing-remitting multiple sclerosis (1991) (5)
- Effect of intrastriatal and intranigral administration of synthetic neuromelanin on the dopaminergic neurotoxicity of MPTP in rodents (1987) (5)
- Managing motor fluctuations, dyskinesias, and other adverse effects in Parkinson's disease (1994) (5)
- Regional brain superoxide dismutase activity is altered differently by heat in warm and cool mice (1987) (5)
- MELAS syndrome associated with both A3243G-tRNALeu mutation and multiple mitochondrial DNA deletions (2010) (5)
- Effect of Decortication on Striatal Dopamine Turnover (1983) (5)
- Can nimodipine affect progression of motor neuron disease? A double-blind pilot study. (1994) (5)
- Combined administration of direct dopamine receptor agonists and l-dopa does not interfere with utilization of exogenous l-dopa in rat corpus striatum (1983) (4)
- Effect of l-DOPA on glucose oxidation and incorporation into glycogen in discrete brain regions of the rat (1985) (4)
- Histochemical labeling of β‐adrenergic receptors in the mouse central nervous system by 9‐amino‐acridin propranolol (1978) (4)
- Riluzole, an inhibitor of glutamatergic transmission, suppresses levodopa-induced rotations in 6-hydroxydopamine-lesioned rats. (2003) (4)
- 123I-FP-CIT SPECT Imaging of Dopamine Transporters in Patients with Recurrent Sudden Falls: Are Such Falls a Distinct Entity? (2007) (4)
- Chapter 13 – The Role of Oxidative Stress in the Pathogenesis of Multiple Sclerosis: Current State (2007) (4)
- Posttraumatic-delayed cerebellar syndrome. (1996) (4)
- Effect of papaverine on regional cerebral blood flow of the contralateral hemisphere in patients with acute cerebral infarction. (1979) (4)
- Cerebral blood flow response in non affected hemisphere of patients with acute cerebral infarction. (1977) (4)
- Histochemical evidence for beta-adrenergic receptors in the rat spinal cord. (1976) (4)
- Molecular biology of dopamine-induced apoptosis : possible implications for Parkinson's disease. (2001) (4)
- Update on clinical trials with autologous bone marrow-derived mesenchymal stem cells secreting neurotrophic factors (MSC-NTF) in patients with amyotrophic lateral sclerosis (ALS) (2015) (3)
- Effect of Late Initiation of Levodopa Treatment in Patients With Long-Standing Parkinson's Disease (2003) (3)
- Erratum: Levodopa in the treatment of Parkinson's disease: Current controversies (Movement Disorders) (2004)) (2005) (3)
- Does treatment with dopamine agonists affect utilization of exogenous levodopa in the parkinsonian striatum? (1995) (3)
- Altered pharmacokinetics of l‐dopa metabolism (1985) (3)
- Erratum: VPS35 mutations in Parkinson disease (American Journal of Human Genetics (2011) 89 (162-167)) (2011) (3)
- Chronic L-Dopa Therapy in Parkinson’s Disease: Can It Accelerate Degeneration of Nigrostriatal Dopaminergic Neurons? (1990) (3)
- The role of glutamatergic transmission in the pathogenesis of levodopa-induced dyskinesias. Potential therapeutic approaches. (2001) (3)
- Changes in T‐cell subpopulations in multiple sclerosis (1989) (3)
- A comparative study of rasagiline versus placebo or entacapone as adjunt to levodopa in Parkinson's disease (PD) patients with motor fluctuations (the LARGO Study). (2004) (2)
- IL-3-LA production by mononuclear cells of patients with multiple sclerosis: effect of treatment with intravenous immunoglobulins. (1995) (2)
- The hyperperfusion syndrome: an under-recognized complication of carotid endarterectomy. (2004) (2)
- Sensory symptoms in Parkinson's disease. (2007) (2)
- Treatment of Multiple Sclerosis With Intravenous Immunoglobulins-Reply (1994) (2)
- [Superior sagittal sinus thrombosis: clinical picture and computed tomographic findings]. (1985) (2)
- Biochemical effects of chronic L-dopa treatment in rats: implications for emergence of tolerance phenomena in patients with Parkinson's disease. (1987) (2)
- 15.14 Validation of the freezing of gait questionnaire (FOG-Q) in Parkinson's disease (2005) (2)
- Noradrenergic mediation of adrenocortical responses following cortical stimulation in the rat. (1986) (2)
- POSTTRAUMATIC-DELAYED CEREBELLAR SYNDROME. AUTHORS' REPLY (1996) (1)
- Regional Cerebral Blood Flow in Dementing Disorders (1986) (1)
- B14 Neurotrophic factors secreting mesenchymal stem cells attenuate quinolinic acid induced striatal lesion model suggesting autologous therapy for HD (2010) (1)
- [Aluminium and Alzheimer's disease]. (1990) (1)
- Induction of T-complex protein-1 (TCP-1) expression during dopamine-triggered neuronal apoptosis in chick embryo sympathetic neurons (1997) (1)
- 3.020 DJ-1 BASED PEPTIDE AS A NOVEL NEUROPROTECTIVE STRATEGY IN PARKINSON'S DISEASE (2012) (1)
- [Neurological complications in Down's Syndrome]. (2002) (1)
- Autologous Transplantation of Mesenchymal Stem Cells Secreting Neurotrophic Factors (Nurown™) In ALS: Results of a Phase 2 Clinical Trial (P2.059) (2015) (1)
- Design guidelines for embedded real time face detection application (2011) (1)
- Transgenic mice expressing human BCL-2 in their neurons are resistant to neurotoxicity of 6-OH-dopamine and MPTP (1997) (1)
- Toxic causes of parkinsonism. (2007) (1)
- Studies on serotonergic and catecholaminergic systems in mice after prenatal exposure to phenobarbital (1985) (1)
- BONE-MARROW-DERIVED MESENCHYMAL STEM CELL THERAPY FOR NEURODEGENERATINE DISEASES (2009) (1)
- [Syringomyelic form of leprosy]. (1989) (1)
- Recent Advances in ALS Research: Perspectives for Personalized Clinical Application (2013) (1)
- beta-Adrenergic receptors in rat cerebral cortex: histochemical localization by a fluorescent beta-blocker. (1977) (1)
- [Measurement of cognitive functions in Parkinson's disease]. (1986) (0)
- Dopamine induced programmed cell death (apoptosis) in postmitotic neurons - Implications for the pathogenesis of Parkinson's disease (1997) (0)
- [Dexamethasone treatment in acute bacterial meningitis]. (1990) (0)
- Parkinson's disease in a patient with mitochondrial myopathy: Is there a causative relationship? (1992) (0)
- [Cerebral blood flow in hypertension]. (1982) (0)
- Composition of l-dopa ester (1993) (0)
- L-dopa ester composition containing (1993) (0)
- Comprar Parkinson's Disease and Related Disorders Part II | William C. Koller | 9780444528933 | Elsevier (2007) (0)
- pharmaceutical composition of ethyl l-dopa. (1996) (0)
- Parkinson's disease and related disorders (2007) (0)
- Levodopa and Posture - Quantification of Trunk Performance in Parkinson’s Disease (P3.063) (2014) (0)
- Corrigendum to “Novel molecular imaging of cell death in experimental cerebral stroke” [Brain Res. 1144 (2007) 156–164] (2012) (0)
- Transplantation of Placenta-Derived Mesenchymal Stem Cells in the EAE Mouse Model of MS (2012) (0)
- Hyperglycemia and brain damage (1984) (0)
- Bone marrow stem cells: possible source for cell therapy in Parkinson’s disease (2005) (0)
- The site of decarboxylation of exogenous L-dopa in the rat striatum (1981) (0)
- Method L-DOPA ethyl ester-containing composition for the preparation of (1993) (0)
- DJ-1 Based Peptide as a Novel Neuroprotective Strategy for Parkinson's Disease (SC02.003) (2012) (0)
- Parkinson's disease with camptocormia. Commentary (2006) (0)
- Stem Cells as a Source for Cell Replacement in Parkinson’s Disease (2006) (0)
- [Apomorphine for treatment of "off-periods" in Parkinson's disease]. (1999) (0)
- Left-handedness and multiple sclerosis (1994) (0)
- Reference VPS 35 mutations in Parkinson disease (2017) (0)
- Intravenous immunoglobulin treatment in multiple sclerosis. (1995) (0)
- [Steroid treatment in brain edema]. (1983) (0)
- Anti Sema3A antibodies rescue retinal ganglion cells from cell death following optic nerve axotomy (2002) (0)
- Successful treatment of truncal myoclonus (2007) (0)
- Adrenocortical secretion following photic stimulation mediated by medial forebrain bundle catecholaminergic fibers. (1983) (0)
- Clinical aspects and noninvasive diagnostic approaches (1986) (0)
- Transplantation of human MSC in experimental neurodegenerative diseases (2011) (0)
- Internal Carotid Arterial Occlusion Simulating Extracerebral Hematoma: Relation to Diagnosis of Stroke (1976) (0)
- Huntington Chorea: Is It Associated with Hyperactivity of Nigrostriatal Dopaminergic Neurons?: 5—3:30 (1981) (0)
- Compositions d'esters de la l-dopa (1993) (0)
- Ziv Levodopa – an exotoxin or a therapeutic drug ? (0)
- ENS TEACHING REVIEW (2001) (0)
- Composition d'esters du L-dopa (1993) (0)
- Composition pharmaceutique a base d'ester ethylique de levodopa (1996) (0)
- Knocking Out DJ-1 Attenuates Astrocytes Neuroprotection Against 6-Hydroxydopamine Toxicity (2013) (0)
- MRI and MRSI characterization of the Quinolinic acid lesion model of Huntington ' s disease over 49 days : Persistence of low apparent diffusion coefficients and spontaneous recovery of N-Acetyl Aspartate levels (2008) (0)
- I11 Longitudinal MRI and MRSI characterisation of the quinolinic acid rat model for excitotoxicity: unique recovery of N-acetyl aspartate levels (2010) (0)
- Intravitreal Injections of Neurotrophic Factors Secreting Mesenchymal Stem Cells Are Neuroprotective in Post Optic Nerve-Transected Rat Eyes (2009) (0)
- Extreme anticipation in young‐onset Parkinson's disease (1998) (0)
- A pharmaceutical composition of L-DOPA ethyl ester (1996) (0)
- and populations isolated cells comprising the same for treatment of CNS diseases (2006) (0)
- Folic acid and the nervous system. (1983) (0)
- Transcription Factors Analysis in Neuronal-Like Cells Derived from Adult Human Bone Marrow. (2004) (0)
- Chronic dopa feeding of mice (1982) (0)
- histochemical study with a fluorescent beta-blocker Direct evidence for absence of beta-adrenergic receptors in rat cerebral vessels (2011) (0)
- The G2019S LRRK2 mutation: Another morbid burden for Ashkenazi Jews may provide new insights on sporadic Parkinson's disease (2013) (0)
- Ester composition l-dopa. (1993) (0)
- L-DOPA ester compositions (1993) (0)
- BASIC SCIENCE (1996) (0)
- TREATMENT OF MULTIPLE SCLEROSIS WITH INTRAVENOUS IMMUNOGLOBULINS. AUTHORS'REPLY (1994) (0)
- Dossier : Neurological disorders : Clinical challenges and controversies Long-term Parkinson ’ s disease e Time for optimism (0)
- Future Symptomatic Therapy in Parkinson’s Disease (2004) (0)
- Bent spine and knees in Parkinson’s disease (2008) (0)
- Comprar Parkinsons Disease and Related Disorders Part I | William C. Koller | | Elsevier (2007) (0)
- B15 Rat bone marrow derived mesenchymal stem cells post differentiation to neurotrophic factor secreting cells migrate towards quinolinic acid lesion (2010) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Eldad Melamed?
Eldad Melamed is affiliated with the following schools:
